MRC1 and ovarian carcinoma: In this exploratory pilot study, we evaluated different ovarian cancer tumor biopsies for the presence of total TAM (cluster of differentiation (CD) 68 expression), M1 (major histocompatibility complex (MHC) II expression), and M2 (anti-mannose receptor C type 1 (MRC1) expression), and for the blood vessel diameter.